Klotho inhibits angiotensin II-induced cardiac hypertrophy, fibrosis, and dysfunction in mice through suppression of transforming growth factor-β1 signaling pathway

被引:56
|
作者
Ding, Jieqiong [1 ,2 ]
Tang, Qiong [1 ,2 ]
Luo, Binhua [3 ]
Zhang, Lijun [1 ]
Lin, Li [1 ]
Han, Lu [1 ]
Hao, Miaomiao [3 ]
Li, Mingyue [3 ]
Yu, Liangzhu [1 ,2 ]
Li, Mincai [1 ,2 ]
机构
[1] Hubei Univ Sci & Technol, Sch Basic Med Sci, Xianning 437100, Peoples R China
[2] Hubei Univ Sci & Technol, Hubei Key Lab Cardiovasc Cerebrovasc & Metab Diso, Xianning 437100, Peoples R China
[3] Hubei Univ Sci & Technol, Sch Pharm, Xianning 437100, Peoples R China
基金
中国国家自然科学基金;
关键词
Klotho; Hypertrophy; Fibrosis; Transforming growth factor-beta 1; Angiotensin II; LEFT-VENTRICULAR HYPERTROPHY; GROWTH-FACTOR-BETA; PROGRESSION; EXPRESSION; RECEPTORS; MODEL;
D O I
10.1016/j.ejphar.2019.172549
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Recent studies have revealed critical roles of transforming growth factor-beta 1 (TGF-beta 1) and microRNA-132 (miR-132), a downstream mediator of TGF-beta 1, in the pathogenesis of cardiac remodeling. In this study, we tested whether the antiaging protein klotho modifies angiotensin II (Ang II)-induced cardiac remodeling through regulating TGF-beta 1-miR-132 axis. We found that both klotho and the TGF-beta 1 inhibitor LY364947 significantly inhibited cardiac hypertrophy, fibrosis, and dysfunction in Ang II-infused mice, as evidenced by the ratios of heart weight to body weight (HW/BW), heart weight to tibial length (HW/TL), cardiomyocyte cross-sectional area, fibrotic area, and expression of prohypertrophic genes (ANP, beta-MHC) and fibrotic marker genes (alpha-SMA, collagen I), echocardiographic parameters. Meanwhile, klotho also significantly inhibited Ang II-induced protein expression of TGF-beta 1 and phosphorylated Smad2/3 in the heart tissues and cultured cardiomyocytes and cardiac fibroblasts. In vitro experiments demonstrated that Ang II-induced cardiomyocyte hypertrophy and proliferation and activation of cardiac fibroblasts were markedly inhibited by klotho, LY364947 or the miR-132 inhibitor antimiR-beta 2. Both klotho and the TGF-beta 1 inhibitor LY364947 downregulated the miR-132 expression. Additionally, klotho decreased Ang II-induced protein expressions of cardiac fibroblast growth factor (FGF)23 in vivo and in vitro. The decreased protein levels of klotho in serum and renal tissues of Ang II-infused mice were elevated by klotho. Klotho downregulated the protein levels of TGF-beta 1 in renal tissues of Ang II-infused mice. In conclusion, our results suggest that klotho prevents Ang II-induced cardiac remodeling and dysfunction through modifying the TGF-beta 1-miR-132 axis, providing an experimental basis for clinical treatment on cardiac remodeling.
引用
收藏
页数:12
相关论文
共 50 条
  • [31] High density lipoprotein downregulates angiotensin II type 1 receptor and inhibits angiotensin II-induced cardiac hypertrophy
    Lin, Li
    Gong, Hui
    Ge, Jingyi
    Jiang, Guoliang
    Zhou, Ning
    Li, Lei
    Ye, Yong
    Zhang, Guoping
    Ge, Junbo
    Zou, Yunzeng
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2011, 404 (01) : 28 - 33
  • [32] IRF3 regulates cardiac fibrosis but not hypertrophy in mice during angiotensin II-induced hypertension
    Tsushima, Kensuke
    Osawa, Tomoko
    Yanai, Hideyuki
    Nakajima, Akira
    Takaoka, Akinori
    Manabe, Ichiro
    Ohba, Yusuke
    Imai, Yasushi
    Taniguchi, Tadatsugu
    Nagai, Ryozo
    FASEB JOURNAL, 2011, 25 (05): : 1531 - 1543
  • [33] Heme oxygenase-1 inhibits angiotensin II-induced cardiac hypertrophy in vitro and in vivo
    Hu, CM
    Chen, YH
    Chiang, MT
    Chau, LY
    CIRCULATION, 2004, 110 (03) : 309 - 316
  • [34] Simvastatin inhibits angiotensin II-induced cardiac cell hypertrophy: Role of Homer 1a
    Guo, Wan-Gang
    Su, Fei-Fei
    Yuan, Li-Jun
    Yang, Guo-Dong
    Shi, Xiao-Qin
    Li, Ruo-Yu
    Shu, Qing
    Liu, Xiong-Tao
    Lu, Zi-Fan
    Zheng, Qiang-Sun
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2010, 37 (01): : 40 - 45
  • [35] Angiotensin II-induced cardiac hypertrophy and hypertension are attenuated by epidermal growth factor receptor antisense
    Kagiyama, S
    Eguchi, S
    Frank, GD
    Inagami, T
    Zhang, YC
    Phillips, MI
    CIRCULATION, 2002, 106 (08) : 909 - 912
  • [36] EGCG inhibits Angiotensin II-induced cardiac hypertrophy in H9C2 via activate HIPPO signaling pathway
    Ma, Yuan
    Li, Jue
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 72 (16) : C82 - C82
  • [38] Transforming growth factor-β inhibits myocardial PPARγ expression in pressure overload-induced cardiac fibrosis and remodeling in mice
    Gong, Kaizheng
    Chen, Yiu-Fai
    Li, Peng
    Lucas, Jason A.
    Hage, Fadi G.
    Yang, Qinglin
    Nozell, Susan E.
    Oparil, Suzanne
    Xing, Dongqi
    JOURNAL OF HYPERTENSION, 2011, 29 (09) : 1810 - 1819
  • [39] Stevioside inhibits transforming growth factor-β1-induced cardiac fibroblast differentiation and collagen synthesis by modulation of Smad signaling pathway
    Wang, Jia
    Jia, Chang-Hao
    Wang, Feng
    Xie, Mei-Lin
    JOURNAL OF FUNCTIONAL FOODS, 2018, 49 : 384 - 390
  • [40] The involvement of transforming growth factor-β1 secretion in Urotensin II-induced collagen synthesis in neonatal cardiac fibroblasts
    Dai, Hong-Yan
    Kang, Wei-Qiang
    Wang, Xu
    Yu, Xiao-Jing
    Li, Zhen-Hua
    Tang, Meng-Xiong
    Xu, Dong-Ling
    Li, Chen-Wen
    Zhang, Yun
    Ge, Zhi-Ming
    REGULATORY PEPTIDES, 2007, 140 (1-2) : 88 - 93